Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04478318 · ClinicalTrials.gov registry record · NA
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
A NA study of Lymphoma and Melanoma, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT04478318 is a NA study of Lymphoma and Melanoma that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 180 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04478318, a NA study of Lymphoma and Melanoma, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the minimum scan duration for fluorine-18 positron-emitting radioactive isotope-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) scans performed on a total-body PET/CT scanner that results in non-inferior image quality to 18F-FDG PET/CT scans performed on a conventional PET/CT scanner. The subject population will be patients being staged for lung cancer, lymphoma, or melanoma.
Conditions Studied
Interventions
- DEVICE uEXPLORER/mCT
- DEVICE mCT/uEXPLORER
Study Locations (1)
California
- University of California Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04478318
The ClinicalTrials.gov registry entry for NCT04478318 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (63% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which uEXPLORER/mCT is the first listed.
NCT04478318 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04478318 about?
NCT04478318 is a clinical study titled "Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma". To determine the minimum scan duration for fluorine-18 positron-emitting radioactive isotope-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) scans performed on a total-body PET/CT scanner that results in non-inferior image quality to 18F-FDG PET/CT scans perf...
What is the current status of trial NCT04478318?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2020-06-01. Estimated completion is 2026-06-01.
What conditions does trial NCT04478318 study?
This clinical trial studies the following conditions: Lymphoma, Melanoma, Lung Neoplasm, Positron Emission Tomography, Fluorodeoxyglucose.
What interventions are being tested in trial NCT04478318?
The interventions under investigation include: uEXPLORER/mCT (DEVICE), mCT/uEXPLORER (DEVICE).
Who is sponsoring clinical trial NCT04478318?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04478318 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.